Soraya Saiagh
Nantes, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
NIVO-TIL: combination anti-PD-1 therapy and adoptive T-cell transfer in untreated metastatic melanoma: an exploratory open-label phase I trial.
Journal: Acta oncologica (Stockholm, Sweden)
Published: April 03, 2024
Can academic structures improve access to CAR-T cells?
Journal: Bulletin du cancer
Published: September 08, 2023
A Phase I/IIa study of autologous tolerogenic dendritic cells immunotherapy in kidney transplant recipients.
Journal: Kidney international
Published: March 22, 2022
A phase I/II feasibility vaccine study by autologous leukemic apoptotic corpse-pulsed dendritic cells for elderly AML patients.
Journal: Human vaccines & immunotherapeutics
Published: June 21, 2021
Phase I/II clinical trial of adoptive cell transfer of sorted specific T cells for metastatic melanoma patients.
Journal: Cancer immunology, immunotherapy : CII
Published: January 05, 2021
Tumor infiltrating lymphocytes as adjuvant treatment in stage III melanoma patients with only one invaded lymph node after complete resection: results from a multicentre, randomized clinical phase III trial.
Journal: Cancer immunology, immunotherapy : CII
Published: August 27, 2019
The doubling potential of T lymphocytes allows clinical-grade production of a bank of genetically modified monoclonal T-cell populations.
Journal: Cytotherapy
Published: August 18, 2017
Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes in Advanced Melanoma Patients.
Journal: Journal of immunology research
Published: July 18, 2017
Adoptive T cell therapy combined with intralesional administrations of TG1042 (adenovirus expressing interferon-γ) in metastatic melanoma patients.
Journal: Cancer immunology, immunotherapy : CII
Published: October 24, 2014
Last Updated: 09/26/2026